ALMR Alamar Biosciences, Inc.
ALMR Alamar Biosciences, Inc.
Healthcare · Medical Devices
Market read
POC $24.47 · VWAP $27.48 · -8.0% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
ALMR Price Structure
Loading timeframes…
Peers
Every watchlist ALMR belongs to, members best 30-day change first — ALMR highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
Alamar Biosciences furnished its earnings release to the SEC on August 10, 2026 (8-K, Item 2.02) and filed its 10-Q for the quarter ended June 30, 2026 on August 11, 2026. Its 10-Q reports (GAAP): revenue $29M, diluted EPS -$0.22, net income -$13M.
full note →Against street estimates
How ALMR's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about ALMR from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 10 days ago · Oct 7
- Alamar Biosciences (ALMR) Stock Price, News & Analysis
- Alamar Biosciences Inc (ALMR) (Q2 2026) Earnings Call ...
- Alamar Biosciences Stock Price Forecast. Should You Buy ALMR?
- Alamar Biosciences (Nasdaq:ALMR) - Stock Analysis - Simply Wall St
- NASDAQ:ALMR Financials | Alamar Biosciences Inc - Investing.com
- Investor Relations | Alamar Biosciences, Inc.
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
ALMR research tape
3 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.